Results 191 to 200 of about 2,024,119 (265)

What is in the Dust? Species‐Level Profiling Reveals Pathogenic and Protective Potential of Microbial Communities in Daycare and Home Environments

Environmental Microbiology Reports, Volume 18, Issue 5, October 2026.
Daycare and home dust predominantly harbour commensal and environmental bacteria; however, a significant proportion remains unclassified, indicating routine childhood exposure to novel microorganisms. Both environments contain species with probiotic and immunostimulatory properties that may confer protection against non‐communicable diseases including ...
Jill A. McKay, Richard Harding‐Crooks, Vartul Sangal   +2 more
wiley   +1 more source

Optimization of Resazurin Microplate Assay (REMA) in Evaluating Anti-MRSA and Anti-MSSA Activities. [PDF]

Acta Med Philipp
Garong CJC, Burigsay NPF, Gapultos RS, Mandawe JLB, Pedrosa RMV, Dayrit GB.   +5 more
europepmc   +1 more source

Mast Cells in Host Defense Against Cutaneous Staphylococcus aureus Infection

Immunology &Cell Biology, Volume 104, Issue 9, Page 867-880, October 2026.
Impact of S. aureus epicutaneous sensitization models on mast cell function in vivo. D. farinae and Staphylococcal enterotoxin B (SEB) activate Trpv1+ Tac1+ nociceptors to trigger the release of substance P (SP), which promotes mast cell degranulation through Mrgprb2. S.
Hannah Dychtenberg, Carly Kadonoff, Bailey Lehnert, Priyanka Pundir   +3 more
wiley   +1 more source

Molecular Docking and anti-MRSA effects of bioactive compounds from <i>Cymbopogon</i>. [PDF]

In Silico Pharmacol
Vinutha M, Manikandan A, Lakshmikanth RN, Shravani S, Divyashree B, Aishwarya K, Nagaraj MM.   +6 more
europepmc   +1 more source

Genomic Medicine Sweden: Advancing precision medicine at the national level

Journal of Internal Medicine, Volume 300, Issue 4, Page 397-419, October 2026.
Abstract High‐throughput sequencing has transformed clinical diagnostics of rare diseases (RD), cancer and infectious diseases by enabling the identification of disease‐causing genetic alterations and facilitating individualised treatment and care.
Anders Edsjö, Anna Lindstrand, Panagiotis Baliakas, David Gisselsson, Paula Mölling, Mia Wadelius, Åsa Johansson, Hannes Olauson, Hans Ehrencrona, Lovisa Lovmar, Christian G. Giske, Henrik Green, Ann Nordgren, Fulya Taylan, Martin Hallbeck, Erika Tång Hallbäck, Anna Green, Markus Heidenblad, Kina Höglund, Anders Jemt, Carl Mårten Lindqvist, Maria Johansson Soller, Magnus Sabel, Colum Walsh, Hartmut Vogt, Craig E. Wheelock, Martin Bergö, Jens Enoksson, Ann Ekberg Jansson, Cecilia Fagerström, Jan Holgersson, Stephanie Anja Juran, Mats G. Karlsson, Frida Lundmark, Eva Tiensuu Janson, Andreas Muranyi Scheutz, Malin Sund, Päivi Östling, Sofia Gruvberger‐Saal, Marene Landström, Malin Melin, Lars Palmqvist, Richard Palmqvist, Bianca Stenmark, Anna Wedell, Malin Karnå, Katarina Nyström, Tobias Strid, Per Sikora, Maria Johansson, Therese Fagerqvist, Mirja Carlsson Möller, Oskar Frisell, Mats Ulfendahl, Mikaela Friedman, Lucia Cavelier, Valtteri Wirta, Thoas Fioretos, Richard Rosenquist   +58 more
wiley   +1 more source

From Natural Products to Small Molecules: Recent Advancements in Anti-MRSA Therapeutics. [PDF]

ACS Med Chem Lett
Smith JR, LeBlanc AR, Wuest WM.
europepmc   +1 more source

Unearthing anti-MRSA agents from alpine lichens: discovery and characterization of bioactive compounds in <i>Cetraria islandica</i> from the snowy Cangshan region. [PDF]

Front Microbiol
Lu J, Tian H, Liang F, Xiang Z, Liu M, Ding H.   +5 more
europepmc   +1 more source

Bioactivity-Guided Isolation of Flavone Glycoside from <i>Terminalia catappa</i>: Evaluating Anti-MRSA and Anti-Dermatophytic Potential. [PDF]

Molecules
Sowmya TN, Gurudatt DM, Raveesha KA.
europepmc   +1 more source

First vanguard anti-MRSA agent approved [PDF]

Nature Biotechnology, 2014
openaire   +1 more source

Anti-MRSA effects of synergism of recombinant lysostaphin with biosynthesized silver nanoparticles. [PDF]

Open Vet J
Saleh ZF, Mizher BM.
europepmc   +1 more source